OBJECTIVE: For rheumatoid arthritis (RA), there is no consensus on how to define and assess flare. Variability in flare definitions impairs understanding of findings across studies and limits ability to pool results. The OMERACT RA Flare Group sought to identify domains to define RA flares from patient and healthcare professional (HCP) perspectives. METHODS: Flare was described as a worsening of disease activity of sufficient intensity and duration to consider a change in therapy. International patients and HCPs participated in separate and combined rounds of Delphi exercises to rate candidate flare domains previously generated in patient focus groups. Core domains were defined as those with ≥70% ratings of being 'essential' according to the third/final Delphi exercise. RESULTS: The final Delphi included 125 RA patients from 10 countries and 108 HCPs from 23 countries who rated 14 domains. Patients had a mean (±SD) age of 56±12 years and disease duration of 18±12 years. HCPs included physicians from clinical practice/research and industry, allied health providers and researchers with 17±11 years experience. Core domains comprised: pain (93%), function (89%), swollen joints (84%), tender joints (81%), participation (81%), stiffness (79%), patient global assessment (76%) and self-management (75%). Fatigue (68%), which did not reach group consensus, will receive additional consideration. CONCLUSIONS: As part of the process to develop a measure for RA flare, patients and HCPs agreed on eight core domains. Next steps include identifying items to assess domains and conducting studies to validate and refine a new measure.
OBJECTIVE: For rheumatoid arthritis (RA), there is no consensus on how to define and assess flare. Variability in flare definitions impairs understanding of findings across studies and limits ability to pool results. The OMERACT RA Flare Group sought to identify domains to define RA flares from patient and healthcare professional (HCP) perspectives. METHODS: Flare was described as a worsening of disease activity of sufficient intensity and duration to consider a change in therapy. International patients and HCPs participated in separate and combined rounds of Delphi exercises to rate candidate flare domains previously generated in patient focus groups. Core domains were defined as those with ≥70% ratings of being 'essential' according to the third/final Delphi exercise. RESULTS: The final Delphi included 125 RA patients from 10 countries and 108 HCPs from 23 countries who rated 14 domains. Patients had a mean (±SD) age of 56±12 years and disease duration of 18±12 years. HCPs included physicians from clinical practice/research and industry, allied health providers and researchers with 17±11 years experience. Core domains comprised: pain (93%), function (89%), swollen joints (84%), tender joints (81%), participation (81%), stiffness (79%), patient global assessment (76%) and self-management (75%). Fatigue (68%), which did not reach group consensus, will receive additional consideration. CONCLUSIONS: As part of the process to develop a measure for RA flare, patients and HCPs agreed on eight core domains. Next steps include identifying items to assess domains and conducting studies to validate and refine a new measure.
Authors: Muirne C S Paap; Christina Bode; Lonneke I M Lenferink; Caroline B Terwee; Job van der Palen Journal: Qual Life Res Date: 2014-11-16 Impact factor: 4.147
Authors: Kazuki Yoshida; Yoon-Kyoung Sung; Arthur Kavanaugh; Sang-Cheol Bae; Michael E Weinblatt; Mitsumasa Kishimoto; Kazuo Matsui; Shigeto Tohma; Daniel H Solomon Journal: Ann Rheum Dis Date: 2013-05-30 Impact factor: 19.103
Authors: Clifton O Bingham; Susan J Bartlett; Peter A Merkel; Thelma J Mielenz; Paul A Pilkonis; Lauren Edmundson; Emily Moore; Rajeev K Sabharwal Journal: Qual Life Res Date: 2016-02-25 Impact factor: 4.147
Authors: S J Bartlett; A K Gutierrez; A Butanis; V P Bykerk; J R Curtis; S Ginsberg; A L Leong; A Lyddiatt; W B Nowell; A M Orbai; K C Smith; C O Bingham Journal: Qual Life Res Date: 2018-05-24 Impact factor: 4.147
Authors: John R Kirwan; Maarten Boers; Sarah Hewlett; Dorcas Beaton; Clifton O Bingham; Ernest Choy; Philip G Conaghan; Maria-Antonietta D'Agostino; Maxime Dougados; Daniel E Furst; Francis Guillemin; Laure Gossec; Désirée M van der Heijde; Margreet Kloppenburg; Tore K Kvien; Robert B M Landewé; Sarah L Mackie; Eric L Matteson; Philip J Mease; Peter A Merkel; Mikkel Ostergaard; Lesley Ann Saketkoo; Lee Simon; Jasvinder A Singh; Vibeke Strand; Peter Tugwell Journal: J Rheumatol Date: 2014-03-15 Impact factor: 4.666
Authors: Vivian P Bykerk; Elisabeth Lie; Susan J Bartlett; Rieke Alten; Annelies Boonen; Robin Christensen; Daniel E Furst; Sarah Hewlett; Amye L Leong; Anne Lyddiatt; Lyn March; James E May; Pam Montie; Ana-Maria Orbai; Christoph Pohl; Marieke Scholte Voshaar; Thasia Woodworth; Clifton O Bingham; Ernest H Choy Journal: J Rheumatol Date: 2014-03-01 Impact factor: 4.666
Authors: Ethan T Craig; Jamie Perin; Scott Zeger; Jeffrey R Curtis; Vivian P Bykerk; Clifton O Bingham; Susan J Bartlett Journal: Arthritis Care Res (Hoboken) Date: 2020-11 Impact factor: 4.794